Abstract
The invention relates generally to the treatment of multiple myeloma. One embodiment of the invention provides a method of treating multiple myeloma (MM) in an individual, the method comprising: administering to the individual an effective amount of trichostatin A (TSA).
Full Text
What is claimed is:
The invention relates generally to the treatment of multiple myeloma. One embodiment of the invention provides a method of treating multiple myeloma (MM) in an individual, the method comprising: administering to the individual an effective amount of trichostatin A (TSA).
Timeline
Filed
06/11/2026Published
10/01/2026Granted
Not AvailableIPC Codes(3)
A61K 31/165:having aromatic rings, e.g. colchicine, atenolol, progabide
A61K 9/00:Medicinal preparations characterised by special physical form
A61P 35/00:Antineoplastic agents